Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 30% ± 9% |
Insufficient scRNA-seq data for expression of CCNA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 89% | 219.26 | 152 / 170 | 30% | 8.92 | 138 / 459 |
ovary | 23% | 18.56 | 41 / 180 | 91% | 57.07 | 392 / 430 |
brain | 79% | 452.07 | 2078 / 2642 | 30% | 2.45 | 215 / 705 |
lung | 53% | 106.92 | 308 / 578 | 31% | 8.32 | 356 / 1155 |
adrenal gland | 24% | 24.80 | 63 / 258 | 49% | 6.53 | 113 / 230 |
thymus | 26% | 31.38 | 171 / 653 | 40% | 2.94 | 245 / 605 |
peripheral blood | 57% | 291.82 | 531 / 929 | 0% | 0 | 0 / 0 |
breast | 39% | 38.26 | 177 / 459 | 10% | 1.50 | 114 / 1118 |
esophagus | 8% | 10.59 | 115 / 1445 | 37% | 18.13 | 68 / 183 |
intestine | 28% | 23.21 | 271 / 966 | 1% | 0.15 | 6 / 527 |
spleen | 27% | 38.80 | 66 / 241 | 0% | 0 | 0 / 0 |
kidney | 19% | 18.63 | 17 / 89 | 5% | 0.56 | 48 / 901 |
skin | 10% | 10.27 | 184 / 1809 | 14% | 2.74 | 67 / 472 |
tonsil | 0% | 0 | 0 / 0 | 20% | 3.87 | 9 / 45 |
bladder | 5% | 2.62 | 1 / 21 | 13% | 3.90 | 67 / 504 |
prostate | 17% | 23.07 | 42 / 245 | 0% | 0.04 | 2 / 502 |
muscle | 17% | 68.47 | 133 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 14% | 11.24 | 191 / 1335 | 0% | 0 | 0 / 0 |
adipose | 12% | 10.29 | 139 / 1204 | 0% | 0 | 0 / 0 |
stomach | 8% | 6.74 | 30 / 359 | 1% | 0.05 | 2 / 286 |
heart | 5% | 5.57 | 41 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 4% | 0.88 | 8 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 2.75 | 1 / 29 |
liver | 2% | 1.57 | 4 / 226 | 1% | 0.07 | 3 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000079 | Biological process | regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0007283 | Biological process | spermatogenesis |
GO_0051301 | Biological process | cell division |
GO_0044772 | Biological process | mitotic cell cycle phase transition |
GO_0007141 | Biological process | male meiosis I |
GO_0005813 | Cellular component | centrosome |
GO_0097121 | Cellular component | cyclin A1-CDK1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0097124 | Cellular component | cyclin A2-CDK2 complex |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0097123 | Cellular component | cyclin A1-CDK2 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016538 | Molecular function | cyclin-dependent protein serine/threonine kinase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CCNA1 |
Protein name | Cyclin A1 Cyclin-A1 |
Synonyms | |
Description | FUNCTION: May be involved in the control of the cell cycle at the G1/S (start) and G2/M (mitosis) transitions. May primarily function in the control of the germline meiotic cell cycle and additionally in the control of mitotic cell cycle in some somatic cells. . |
Accessions | ENST00000255465.8 [P78396-3] P78396 F6KX25 ENST00000440264.5 [P78396-3] ENST00000625767.2 [P78396-3] ENST00000630422.2 [P78396-3] |